Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAST kinase domain-containing protein 3, mitochondrial (FASTKD3), is a mitochondria-localized protein encoded by the FASTKD3 gene and part of the FASTK family. FASTKD3 contains an N-terminal mitochondrial targeting sequence, two kinase-like domains (FAST_1 and FAST_2), and a C-terminal RNA-binding domain (RAP). It plays a critical role in mitochondrial respiration by stabilizing and increasing the half-lives of specific mitochondrial mRNAs (e.g., MT-ND2, MT-ND3, MT-CYTB, MT-CO2, and MT-ATP8/6) and promoting their translation. FASTKD3 is required for maintaining cellular energy homeostasis, especially under stress conditions, and is most abundantly expressed in tissues with high mitochondrial content such as skeletal and cardiac muscle. While it interacts with multiple proteins involved in mitochondrial RNA processing, catabolism, translation, and energy production, FASTKD3 itself has no confirmed kinase activity and is not considered a classical therapeutic drug target or disease biomarker at present.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FAST kinase domain-containing protein 3, mitochondrial (FASTKD3).